1224724-39-3

Basic information

• Product Name: 1H-Indole-7-carboxylic acid, 4-broMo-, Methyl ester
• Synonyms: 1H-Indole-7-carboxylic acid, 4-broMo-, Methyl ester;Methyl 4-broMo-1H-indole-7-carboxylate
• CAS NO: 1224724-39-3
• Molecular Formula: C₁₀H₈BrNO₂
• Molecular Weight: 254.08002
• Mol File: 1224724-39-3.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 402.3±25.0 °C(Predicted)
• Appearance: /
• Density: 1.629±0.06 g/cm3(Predicted)
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 14.49±0.30(Predicted)
• CAS DataBase Reference: 1H-Indole-7-carboxylic acid, 4-broMo-, Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Indole-7-carboxylic acid, 4-broMo-, Methyl ester(1224724-39-3)
• EPA Substance Registry System: 1H-Indole-7-carboxylic acid, 4-broMo-, Methyl ester(1224724-39-3)

Safety Data

• Hazardous Substances Data: 1224724-39-3(Hazardous Substances Data)

Usage

General Description

1H-Indole-7-carboxylic acid, 4-bromo-, methyl ester is a chemical compound with the formula C11H9BrNO2. It is a methyl ester derivative of 1H-Indole-7-carboxylic acid, which is a naturally occurring compound found in various plants and animals. The 4-bromo substitution on the indole ring makes this compound potentially useful in medicinal chemistry for the development of new drugs. It may have biological activities and therapeutic properties that could be explored for potential pharmaceutical applications. 1H-Indole-7-carboxylic acid, 4-bromo-, methyl ester can be synthesized through chemical reactions and is commonly used as a reagent in organic synthesis and pharmaceutical research.

Upstream product

• 99277-71-1 4-bromo-2-nitrobenzoic acid 
• 1826-67-1 vinyl magnesium bromide 
• 158580-57-5 methyl 4-bromo-2-nitrobenzoate 
• 1211594-25-0 4-bromo-1H-indole-7-carboxylic acid 
• 74-88-4 methyl iodide 

Downstream Products

• 1312610-55-1 C₄₄H₅₉N₇O₅Si 
• 1312608-64-2 C₄₂H₅₁N₉O₆ 
• 1211596-82-5 4-bromo-1H-indole-7-carboxamide 
• 1309980-17-3 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-7-carboxamide 

Relevant articles and documents

Compound serving as protein kinase inhibitor and application of compound

The invention discloses a compound used as a protein kinase inhibitor and application of the compound, the compound has an obvious inhibition effect on protein kinase activity, can be used as a BTK inhibitor for preparing medicines for treating BTK-mediated diseases such as malignant tumors, autoimmune diseases and the like, and has wide application prospect.

SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE

The present invention provides compounds of Formula (I) or a subgeneric structure or species thereof, or a pharmaceutically acceptable salt, ester, solvate, and/or prodrug thereof, and methods and compositions for treating or ameliorating abnormal cell proliferative disorders, such as cancer, wherein A, R2, R3, R10, E1, E2, E3, Y, and Z are as defined herein.

PRIMARY CARBOXAMIDES AS BTK INHIBITORS

The invention provides carboxamide compounds of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions, including rheumatoid arthritis, juvenile rheumatoid arthritis, osteoarthritis, Crohn's disease, inflammatory bowel disease, ulcerative colitis, psoriatic arthritis, psoriasis, ankylosing spondylitis, interstitial cystitis, asthma, systemic lupus erythematosus, lupus nephritis, B cell chronic lymphocytic lymphoma, multiple sclerosis, chronic lymphocytic leukemia, small lymphocytic lymphoma, mantle cell lymphoma, B-cell non-Hodgkin's lymphoma, activated B-celllike diffuse large B-cell, lymphoma, multiple myeloma, diffuse large B-celllymphoma, follicular lymphoma, hairy cell leukemia or Lymphoblastic lymphoma.